Pharmaceutical company Boehringer Ingelheim has joined hands with blockchain-powered healthcare solution provider Solve.Care.
The German company, which is listed in the top 20 list of global pharmaceutical firms, and Solve.Care are making groundwork to create a blockchain and digital asset-backed network for dependable sharing of information about diabetes patients.
The latest healthcare system, which is based on Solve.Care’s blockchain platform, is referred to as the Diabetes Care Administration Network.
The network aims to offer assistance in organizing care for patients and also to distribute knowledge about the perils linked with diabetes, signs and aversion, to name a few.
The network will supposedly employ Solve.Care’s care collaboration tool named Care.Wallets in order to assist patients suffering from disease.
The care network is anticipated to be put into operation before this year end. Furthermore, the system is planned to be unveiled for use by over 25,000 patients across Arizona Care Network (ACN), a top American accountable care firm.
Of late, the largest chain store in the US, Walmart became a member of MediLedger, a blockchain-powered pharmaceutical consortium, following four top US enterprises in the sector, including Pfizer.
It can be remembered that the Association of amyotrophic lateral sclerosis (ALS) collaborated with a key cryptocurrency venture, the Tron Foundation, to unveil a blockchain-based charity drive to create cognizance about ALS and amass donations for disease therapy research.
